Abstract:Purpose Adverse drug events (ADEs) are a significant global public health concern, and they have resulted in high rates of hospital admissions, morbidity, and mortality. Prior to the use of machine learning and deep learning methods, ADEs may not become well recognized until long after a drug has been approved and is widely used, which poses a significant challenge for ensuring patient safety. Consequently, there is a need to develop computational approaches for earlier identification of ADEs not detected during pre-registration clinical trials. Methods This paper presents a state-of-the-art network-based approach that models patients as subgraphs composed of nodes of International Classification of Diseases (ICD) codes and directed edges illustrating disease progression. Four Graph Neural Network (GNN) variants were employed to make sub-graph level predictions that answer three Research Questions (RQ): 1) whether ADE(s) would occur given a patient's prior diagnoses history, 2) when an ADE would occur, and 3) which ADE would occur. The first and second RQs were addressed using a binary classification approach. The third RQ was addressed using a multi-label classification model. Results The proposed network-based approach demonstrated superior performance in predicting ADEs, with the GraphSage model exhibiting the highest accuracy for both RQ 1 (0.8863) and RQ 3 (0.9367), while the Graph Attention Networks (GAT) model was found to perform best for RQ 2 (0.8769). Furthermore, an analysis segmented by ADE classification revealed that while RQs 1 and 3 exhibited minimal variance across different ADE categories, a distinct advantage was observed for categories B, C, and E in the context of RQ 2 when applying this sub-graph method. Conclusion The network-based approach demonstrates the potential of GNNs in supporting the early detection and prevention of ADEs. Accurately predicting ADEs could enable healthcare professionals to make informed clinical decisions, take preventive measures and adjust medication regimens before serious adverse events occur. The proposed prediction method could also lead to optimized usage of healthcare resources by preventing hospital admissions and reducing the overall burden of adverse drug events on the healthcare systems.

GA-ADE: a Novel Approach Based on Graph Algorithm to Improves the Detection of Adverse Drug Events

Identification of Adverse Drug Events in Chinese Clinical Narrative Text

Graph neural network-based subgraph analysis for predicting adverse drug events

DKADE: a novel framework based on deep learning and knowledge graph for identifying adverse drug events and related medications

Detecting Adverse Drug Event Signals from a Clinical CaseBase.

Knowledge-augmented Graph Neural Networks with Concept-aware Attention for Adverse Drug Event Detection

Predicting Drugs Suspected of Causing Adverse Drug Reactions Using Graph Features and Attention Mechanisms

A method for systematic discovery of adverse drug events from clinical notes.

Prediction of adverse drug reactions based on knowledge graph embedding

Combining a Pharmacological Network Model with a Bayesian Signal Detection Algorithm to Improve the Detection of Adverse Drug Events

GAR: Graph Adversarial Representation for Adverse Drug Event Detection on Twitter.

Development of an adverse drug event network to predict drug toxicity

Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data

mtADENet: A novel interpretable method integrating multiple types of network-based inference approaches for prediction of adverse drug events

Drug-Drug Adverse Effect Prediction with Graph Co-Attention

Detect adverse drug reactions for drug Atorvastatin

A Graph-boosted Framework for Adverse Drug Event Detection on Twitter

Precision Adverse Drug Reactions Prediction with Heterogeneous Graph Neural Network

Adverse drug event and medication extraction in electronic health records via a cascading architecture with different sequence labeling models and word embeddings

CT-ADE: An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results

Feature selection in detection of adverse drug reactions from the Health Improvement Network (THIN) database